baber/WOPTO huggingface dataset:
Patent NZ-534223-A (NZ)
Title: Gamma secretase inhibitors
Inventor: PISSARNITSKI DMITRI A
IPC: A61K31/4535
Filed: 2003-02-05
Abstract: Disclosed are compounds of formula (I) wherein the substituents are as described in the specification. The compounds described are gamma secretase inhibitors useful in the treatment of diseases relating to the deposition of amyloid protein, for example neurodegenerative diseases such as Alzheimer's disease.
Patent NZ-534600-A (NZ)
Title: Substituted isoquinoline derivatives and their use as anticonvulsants
Inventor: HARLING JOHN DAVID
IPC: A61P21/00
Filed: 2000-06-29
Abstract: Disclosed is a compound and process for preparation of formula (I) wherein: Q is a monocyclic or bicyclic aryl or heteroaryl ring; R1 is H; R2 is H, or up to three substituents selected from halogen, NO2, CN, N3, CF3O-, CF3S-, CF3SO2-, CF3CO-, C1-6 alkyl, C1-6 alkenyl, C1-6 alkynyl, C1-6 perfluoroalkyl, C3-6 cycloalkyl, C3-6 cycloalkyl-C1-4 alkyl-, C1-6 alkylO-, C1-6 alkylCO-, C3-6 cycloalkylO-, C3-6 cycloalkylCO-, C3-6 cycloalkyl-C1-4 alkylO-, C3-6 cycloalkyl-C1-4 alkylCO-, phenyl, phenoxy, benzyloxy, benzoyl, phenyl- C1-4 alkyl-, C1-6alkylS-, C1-6 alkylSO2-, (C1-4alkyl)2NSO2-, (C1-4alkyl)2NHSO2-, (C1-4alkyl)2NCO-, (C1-4alkyl)2NHCO-, or CONH2, or ûNR3R4 where R3 and R4 are as defined. Additionally disclosed is the use of formula (I) as a pharmaceutical composition with anti-convulsant properties and is therefore useful in the treatment of anxiety, mania, depression, panic disorders and/or aggression, disorders associated with subarachnoid haemorrhage or neural shock, substance abuse withdrawal and epilepsy amongst others.
Patent NZ-537706-A (NZ)
Title: Probiotic microbial strains, comprising non-pathogenic strains which are capable of surviving in and being transferred to breast milk and/or amniotic fluid after oral intake in healthy individuals without colonizing other internal organs except mucousas
Inventor: PEY JORDI XAUS
IPC: A61K35/74
Filed: 2003-06-26
Abstract: Described is a process for the selection of new probiotic strains which comprises the following steps: a) selecting for non-pathogenic strains which are capable of surviving in breast milk and/or amniotic fluid, and b) selecting for non-pathogenic strains which are able to be transferred to breast milk and/or amniotic fluid after oral intake in healthy individuals without colonising other internal organs except mucousas. Also provided are Lactobacillus strains, which are: CECT5711 (Lactobacillus coryniformis), CECT5713 (Lactobacillus salivarius subsp. salivarius), CECT5714: (Lactobacillus gasseri, formerly L. acidophilus), CETC5715: (Lactobacillus gasseri), and CECT5716: (Lactobacillus fermentum); and refers to their use for the prophylaxis or treatment of digestive, infective, neuro-degenerative and immune related diseases such as allergies or inflammatory diseases.
Patent NZ-539874-A (NZ)
Title: Monoclonal antibodies characterized for their diagnostic value due to their specificity and sensitivity for NT-proBNP and high affinity for NT-proBNP
Inventor: DE BOLD ADOLFO J
IPC: C07K16/26
Filed: 2003-11-17
Abstract: Disclosed herein are hybridoma cell lines 6G11-F11-D12 and IC3-E11-H9 deposited with American Type Culture Collection under Accession Number PTA-4844 and PTA-4845, respectively. Also included are the monoclonal antibodies produced by said hybridoma cell lines disclosed herein.
Patent NZ-547146-A (NZ)
Title: Gasification boiler for solid fuels, in particular for bales of straw, with optimised exhaust gas values
Inventor: HERLT CHRISTIAN
IPC: F23G5/32
Filed: 2004-10-07
Abstract: A gasification boiler for solid fuels, in particular for bales of straw, with optimized exhaust gas values and burn-up at the bottom, is disclosed. The gasification boiler comprises a fuel and gasification space which can be closed by means of a filling door and has air feeds, a grating arranged at the bottom, a combustion space situated below it, an ash separator, heat exchange surfaces, and a fan arranged downstream, characterized: (a) in that the fuel and gasification space has depressions for collecting ash laterally next to the centrally arranged grating and the combustion space, (b) a cylindrical combustion chamber (5) designed as an additional constructional unit is connected to the outlet of the combustion space, and (c) a cylindrical ash separator (6), which is designed as an additional constructional unit and is connected to a known heat exchanger, is connected to the combustion chamber (5).
Patent NZ-560458-A (NZ)
Title: System and method(s) of blended mine planning, design and processing
Inventor: FROYLAND GARY ALLEN
IPC: E21C41/26
Filed: 2003-10-02
Abstract: A method of determining extraction of material from a mine having at least one pit is disclosed. The method comprises the steps of: (a) using a block model to divide the pit into a plurality of blocks, based on predetermined mining parameters; (b) determining a variance of net present value of the mine, having regard to a risk value, so an extraction schedule is determined with respect to that risk value; and (c) ordering the extraction of material to provide the extraction schedule of blocks in the pit.
Patent NZ-562987-A (NZ)
Title: Corneal mask formed of degradation resistant polymer
Inventor: SILVESTRINI THOMAS A
IPC: A61F9/007
Filed: 2006-04-13
Abstract: A mask configured to be implanted in a cornea of a patient. The body of the mask has a light transmitting portion, a light blocking portion disposed about the light transmitting portion, and an outer periphery surrounding the light blocking portion. The mask is adapted to reside between two intracorneal layers of a cornea. The mask is formed from a material comprising a highly fluorinated polymeric material and an opacification agent and is resistant to degradation upon exposure to ultraviolet light.
Patent NZ-565870-A (NZ)
Title: Use of alkoxylated amines to improve water repellency of wood
Inventor: VAN DER FLAAS MARK ARTHUR JOSEPHA
IPC: B05D7/06
Filed: 2006-09-01
Abstract: The disclosure relates to relates to the use of alkoxylated amines of formula (I) wherein: R1 is a C8-20 alkyl; R2 is -[CH2CH(X)O]bH (a-1) or -(CH2)n-N-[CH2CH(X)O]bH (a-2) Ú [CH2CH(X)O]cH n is an integer from 1 to 4; each a, b, and c independently are integers which can be 1 to 20; each X independently is selected from the group consisting of hydrogen, methyl, ethyl, and phenyl; for treating wood and other cellulose materials in order to enhance their water repellent properties and to reduce water uptake when treated wood or other cellulose materials are brought into contact with water.
Patent NZ-567862-A (NZ)
Title: Fungicidal mixtures comprising prothioconazole and dithianon
Inventor: AMMERMANN EBERHARD
IPC: B60Q1/50
Filed: 2003-03-19
Abstract: Disclosed is a fungicidal mixture comprising 2-[2-(1-chlorocyclopropyl)-3-(2-chlorophenyl)-2-hydroxypropyl]-2,4-dihydro-[1,2,4]-triazole-3-thione (prothioconazole) of the formula (I) or a salt or adduct thereof, and dithianon of the formula (VIII), wherein the weight ratio of formula (I) to formula (VIII) is from 20:1 to 1:20.
Patent NZ-571730-A (NZ)
Title: Self-propelled vessel launch and retrieve vehicle
Inventor: MATHEWS KEVIN MICHAEL
Filed: 2008-10-02
Abstract: A self-propelled watercraft launch and retrieve vehicle is disclosed. The vehicle comprises a central chassis 1 which includes a cradle for carrying a boat and from which the boat may be launched from and retrieved onto the vehicle. The chassis has at least one pair of forward wheels 12 and at least one pair of rear wheels. Hydraulic motors are associated with each of the pairs of wheels for driving the wheels. A prime mover or electric motor and a hydraulic pump or pumps driven by the prime mover are mounted at or towards the forward end of the chassis and elevated above the chassis. At least one hydraulic pump is arranged to drive the forward wheels, and at least one other hydraulic pump is arranged to drive the rear wheels. A hand held remote control unit is operable by an operator standing beside or near the vehicle to cause the vehicle to move forward or to reverse and to steer the launch vehicle to the left or right.
Patent NZ-571953-A (NZ)
Title: A system to determine the relationship between animals based on the time they spend close to each other
Inventor: WRIGHT DAVID A
IPC: G06Q50/00
Filed: 2007-03-20
Abstract: A method for determining a relationship between a first animal and a second animal is disclosed. The method comprises the steps of: (i) generating a proximity profile comprising information in relation to the frequency and duration of incidences of proximity for a candidate first animal in relation to the one or more candidate second animals by using data from an electronic identifier on each animal; and (ii) analysing the proximity profile to determine whether the interaction between the candidate first animal and any of the candidate second animals is indicative of a social or genetic relationship between the animals. The electronic identifier may be an RFID device.
Patent NZ-577020-A (NZ)
Title: Diclofenac gel containing dimethyl sulfoxide (dmso)
Inventor: KISAK ED
IPC: A61K9/00
Filed: 2007-10-17
Abstract: Disclosed is a topical formulation, said topical formulation comprising: (i) diclofenac sodium or a non-steroidal anti-inflammatory drug (NSAID); (ii) Dimethyl sulfoxide (DMSO) present at 30-60 per cent; (iii) ethanol; (iv) propylene glycol; (v) optionally glycerol; (vi) a thickening agent, wherein said thickening agent is selected from the group consisting of cellulose polymers, carbomer polymers, a carbomer derivative, a cellulose derivative, polyvinyl alcohol, poloxamers, polysaccharides, and mixtures thereof; and (vii) water, wherein said topical formulation has a viscosity of about 500-5000 centipoise. The formulation is useful in the treatment of pain or osteoarthritis in a subject suffering from articular pain.
Patent NZ-578992-A (NZ)
Title: Multifunction tool for depalletising
Inventor: TAYLOR NEIL
IPC: B26D1/12
Filed: 2009-08-12
Abstract: A multifunction tool 1 for attachment to a controlling device such as a robotic arm, comprising a supporting means carrying a strap cutting mechanism 5 and, a retractable fork lifting mechanism 4 arranged such that cutting of straps around a palletised load and depalletising of the palletised load are carried out using the tool 1 without the palletised load having to be moved from one position to another.
Patent NZ-587309-A (NZ)
Title: Wafer film systems for for the delivery of estrogen or progestin
Inventor: FUNKE ADRIAN
IPC: A61K9/14
Filed: 2009-02-10
Abstract: Disclosed herein is a unit dosage form comprising a thin water-soluble film matrix, wherein said film matrix comprises (a) a polyvinyl alcohol-polyethylene glycol graft copolymer as a water-soluble matrix polymer; (b) an active ingredient being a steroidal estrogen selected from the group of:9alpha-Vinyl-estra-1,3,5(10)-triene-3,16alpha-diol, 17beta-Fluoro-9alpha-vinyl-estra-1,3,5(10)-triene-3,16alpha-diol, 18alpha-Homo-9alpha-vinyl-estra-1,3,5(10)-triene-3,16alpha-diol, 16alpha-Fluoro-8beta-vinyl-estra-1,3,5(10)-triene-3,17alpha-diol, 16alpha-Fluoro-8beta-vinyl-estra-1,3,5(10)-triene-3,17beta-diol, 16beta-Fluoro-8beta-vinyl-estra-1,3,5(10)-triene-3,17beta-diol, 8beta-Vinyl-estra-1,3,5(10)-triene-3,17beta-diol, including therapeutically acceptable derivatives thereof; andsaid film matrix has a thickness of less than 300 microns,wherein said film matrix may also comprise at least a further water-soluble matrix polymer selected from the group of a cellulosic material, a synthetic polymer, a gum, a protein, a starch, a glucan and mixtures thereof.
Patent NZ-589118-A (NZ)
Title: Fluorinated alcohols
Inventor: MCLAIN STEPHAN J
IPC: C07C43/13
Filed: 2009-06-23
Abstract: Disclosed are fluorinated alkylether alcohols of the general formula RfOCFHCF2O(CH2CH2O)v-H; wherein Rf is CcF(2c+1); c is 2 to 6; and v is 2 or 3. Further disclosed is a process for the preparation of a compound as defined above which comprising contacting a compound of the formula Rf-O-CF=CF2, with a compound of the formula HO-(CH2CH2O)v-H in the presence of a base such as alkali metal, alkali earth metal, alkali hydroxide, alkali hydride, or alkali amide.
Patent NZ-593715-A (NZ)
Title: N-alkoxycarboxamides for controlling infestation of plants by microorganisms such as fungi
Inventor: WALTER HARALD
IPC: A01N43/56
Filed: 2010-01-14
Abstract: Disclosed are N-alkoxycarboxamide compounds of formula I, salts thereof and methods for their preparation. The compounds contain terminal pyrazole and thiophene moieties Specific examples of compounds of formula I include: 3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxylic acid methoxy-[1-methyl-2-(2,4,5-trichlorothiophene-3-yl)ethyl]amide, and 3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxylic acid methoxy-[2-methoxy-1-methyl-2-(2,4,5-trichlorothiophene-3-yl)ethyl]amide. The compounds of formula I are microbiocides and particularly fungicidally active. The compounds are useful for controlling or preventing infestation of useful plants by phytopathogenic microorganisms.
Patent NZ-600211-A (NZ)
Title: Fence droppers, fence clips and fencing systems
Inventor: SACHS NICHOLAS
IPC: E04H17/06
Filed: 2012-02-24
Abstract: 600211 A fence clip 26 comprising an elongate wire bent into an asymmetric shape having a central portion 32, an arm 34A, 34B extending from each end of the central portion 32, a hook portion 42 extending from an end of each arm 34A, 34B to capture a fence wire, and at least one lever or lever portion extending from one of the hook portions 42 in a direction away from the central portion 32 which increases the length of the fence clip 26 at least along a positive x-axis.
Patent NZ-602707-A (NZ)
Title: Methods of conditioning sheet bioprosthetic tissue
Inventor: DOVE JEFFREY S
IPC: A61F2/24
Filed: 2011-03-23
Abstract: 602707 Disclosed is a method for preparing bioprosthetic tissue membrane material in vitro, comprising: selecting a mammalian tissue membrane having a fibrous side and a smooth side; and removing at least a portion of material from the fibrous side of the selected membrane by ablating with a very short pulse duration laser to reduce thickness non-uniformity in the fibrous side.   Further disclosed is a method for fabricating a heart valve leaflet in vitro, comprising: selecting a bioprosthetic mammalian tissue membrane having a fibrous side and a smooth side; cross-linking the membrane with a cross-linking solution; forming a heart valve leaflet from the membrane to have an arcuate cusp edge and a free edge opposite the cusp edge; and removing at least a portion of material from the fibrous side of the membrane which forms the heart valve leaflet by ablating with a laser to reduce the thickness of the membrane.   Further disclosed is a method for fabricating a heart valve with bioprosthetic tissue leaflets in vitro, comprising: selecting a bioprosthetic mammalian tissue membrane having opposite sides and a non-uniform thickness; cross-linking the membrane with a cross-linking solution; subjecting the cross-linked membrane to a glycerin-based treatment solution; forming a heart valve leaflet from the membrane to have a peripheral edge region, a free edge opposite the peripheral edge region, and a central region surrounded by the peripheral edge region and free edge; removing material from at least one side of the heart valve leaflet by ablating with a laser to reduce thickness non-uniformity; and attaching a plurality of the heart valve leaflets to a structural stent by connecting the peripheral edge regions of each leaflet to the structural stent to form the heart valve.
Patent NZ-603414-A (NZ)
Title: Association of xanthine oxidase inhibitors and angiotensin ii receptor antagonists and use thereof
Inventor: MELANI FRANCESCO
IPC: A61K31/41
Filed: 2011-05-09
Abstract: ABSTRACT - 603414 The disclosure relates to a combination of active principles, i.e. of a xanthine oxidase inhibitor: febuxostat with one or more angiotensin II receptor antagonists belonging to the class of sartans selected from the group comprising: olmesartan medoximil, candesartan, eprosartan, irbesartan, losartan, telmisartan, valsartan or pharmaceutically acceptable salts thereof, for use in a human or veterinary therapeutic treatment, and methods for the preparation thereof. These compositions are suitable and effective in the therapeutic treatment of hypertension associated to hyperuricemia or to other disorders in the clinical context of the metabolic syndrome.
Patent NZ-608144-A (NZ)
Title: Sugarcane bacilliform viral (scbv) enhancer and its use in plant functional genomics
Inventor: DAVIES JOHN P
IPC: A01H5/10
Filed: 2011-08-29
Abstract: Disclosed is a chimeric transcription regulatory region comprising: -two or more copies of a sugarcane bacilliform viral (SCBV) enhancer element nucleic acid having at least 70% identity to the nucleotide sequence from position 337 to position 618 of SEQ ID NO: 1, as defined in the complete specification; and -operably linked thereto, a heterologous promoter comprising an RNA polymerase binding site and a mRNA initiation site, wherein the chimeric transcription regulatory region enhances the level of transcription of an operably linked nucleic acid of interest relative to the level of transcription of the nucleic acid of interest operably linked to a transcription regulatory region comprising the promoter and not comprising two or more SCBV enhancer elements.
Patent NZ-608545-A (NZ)
Title: Collapsible inclinable exercise device and method of using same
Inventor: CAMPANARO THOMAS J
IPC: A63B21/068
Filed: 2011-08-23
Abstract: An exercise device (100D) is disclosed. The device includes a vertical support member (120), an adjustable incline (140) and a strut (160). The incline has a first end and a second end, the first end vertically movable with respect to the vertical support member for setting the incline of the adjustable incline. The incline has a top rail and a bottom rail pivotally coupled to each other at a first location (A). The strut has a first end and a second end; the first end of the strut being pivotally coupled to the vertical support member and the second end of the strut being pivotally coupled to the adjustable incline at a second location (D) that is not the same as the first location. A user support platform is movably attached to the adjustable incline; pulleys and one or more cables coupled to the adjustable incline and user support platform for movement of the support platform along the adjustable incline.
Patent NZ-609471-A (NZ)
Title: Methods for detecting and identifying a receiver in an inductive power transfer system
Inventor: ROBERTSON DANIEL
IPC: G01R19/00
Filed: 2012-05-02
Abstract: Disclosed is a method for detecting the presence of a receiver (3) in an inductively coupled power transfer system (1). The system (1) includes a transmitter (2) with an inductor (7) for generating an alternating magnetic field, a converter (4) for supplying an alternating current to the inductor (7) and a sensor for measuring the current supplied to the converter (4). The converter (4) is switched on at a first frequency and the amplitude of the current is measured during the inrush period. It is then determined whether the amplitude indicates that there is a receiver (3).
Patent NZ-622418-A (NZ)
Title: Molecular detection assay
Inventor: MILLAR DOUGLAS SPENCER
IPC: C12Q1/68
Filed: 2011-09-07
Abstract: A molecular detection assay comprises treating a biological sample directly with a bisulphite agent under conditions that allow cell disruption and nucleic acid treatment; removing the bisulphite agent from the treated sample; and detecting a target nucleic acid in the treated sample. The assay can be used for detecting infectious disease, genetic disease or genetic trait in an animal.
Patent NZ-628125-A (NZ)
Title: Method for synchronising several cameras with each other in a photographic system, in particular a stereoscopic system, and photographic system for implementing said method
Inventor: MALRAT BENOÎT
IPC: G03B15/02
Filed: 2014-07-31
Abstract: The present invention concerns a method for synchronising several cameras (11, 12) with each other in a photographic system designed to take a multiple view of a scene. The cameras (11, 12) are CCD or CMOS digital type. The method comprises the steps of illuminating the scene by means of a lighting system (30), which the lighting intensity varies periodically. The method further includes setting each of said cameras (11, 12) in a mode where they are themselves synchronised by phase locking on the variations in light intensity of the lighting system. The invention also concerns a photographic system for implementing the method.
Patent NZ-629769-A (NZ)
Title: Topical gels containing alpha connexin c-terminal (act) peptides
Inventor: GHATNEKAR GAUTAM
IPC: A61K38/16
Filed: 2013-03-01
Abstract: Disclosed is a topical formulation comprising at least one alpha connexin polypeptide and hydroxyethylcellulose gel, wherein the hydroxyethylcellulose gel stabilises the alpha connexin polypeptide. Also disclosed is a method of manufacturing a topical formulation comprising: a) mixing propylene glycol, glycerin, methylparaben and propylparaben until the parabens are completely dissolved; b) separately mixing purified water, EOTA, monobasic sodium phosphate, dibasic sodium phosphate and O-mannitol until a clear solution is obtained; c) adding the solution from a) to the solution from b), rinsing the container of the solution from a) with purified water, adding the rinse to the combined solutions, and mixing until the combined solutions are visually homogeneous; d) with homogenisation mixing, adding hydroxyethyl cellulose into the combined solutions of c) and mixing until the polymer is fully dispersed; e) separately mixing purified water with an alpha connexin polypeptide until the peptide is completely dissolved; f) adding the solution from e) to the solution of d), rinsing the container of the solution from e) with purified water, adding the rinse to the combined solutions, and mixing until the combined solution are homogeneous.
Patent NZ-630828-A (NZ)
Title: Compounds and methods for treating aberrant adrenocartical cell disorders
Inventor: HAMMER GARY
IPC: A61P5/38
Filed: 2013-03-13
Abstract: Methods and compositions are provided for treatment of disorders associated with aberrant adrenal cortex cell behavior, including (but not limited to) treatment of adrenocortical carcinoma (ACC), Cushing’ s syndrome and/or pituitary adrenocorticotropic hormone (ACTH) excess (Cushing’ s Disease). Such methods involve administration of an effective amount N-(2,6-bis(1-methylethyl)phenyl)-N’-((1-(4-(dimethylamino)phenyl)cyclopentyl)-methyl)urea hydrochloride to the patient.
Patent NZ-706853-A (NZ)
Title: Vegf neutralizing prodrugs for the treatment of ocular conditions
Inventor: KNAPPE THOMAS
IPC: A61P27/02
Filed: 2013-10-08
Abstract: The present invention relates to a pharmaceutical composition comprising one or more pharmaceutically acceptable excipient(s) and a carrier-linked VEGF neutralizing prodrug, the carrier-linked prodrug comprising a covalently bound VEGF neutralizing biologically active moiety, for use in a method for the treatment of one or more ocular conditions., wherein the carrier-linked prodrug comprises a covalently bound VEGF neutralizing biologically active moiety, a reversible prodrug linker moiety and a carrier group which is a hydrogel, which VEGF neutralizing biologically active moiety is reversibly connected to a carrier through a reversible prodrug linker moiety, wherein there is optionally a spacer moiety between the carrier moiety and the reversible prodrug linker and wherein the reversible prodrug linker is of formula (F) below, for use in a method for the treatment of one or more ocular conditions.